status: 200
content-location: http://rest.kegg.jp/get/map07056
server: Apache
date: Wed, 15 Oct 2014 15:09:53 GMT
content-type: text/plain

ENTRY       map07056          Drug      Pathway
NAME        Agents for Alzheimer-type dementia
PATHWAY_MAP map07056  Agents for Alzheimer-type dementia
COMPOUND    D00196  Physostigmine (USP)
            D00670  Donepezil hydrochloride (JP16/USAN)
            D02068  Tacrine hydrochloride (USP)
            D02173  Galantamine hydrobromide (JAN/USAN)
            D02418  Physostigmine salicylate (JAN/USP)
            D02558  Rivastigmine tartrate
            D03822  Rivastigmine (JAN/USAN/INN)
            D03826  Physostigmine sulfate (USP)
            D04292  Galantamine (USAN/INN)
            D04905  Memantine hydrochloride (JAN/USAN)
            D06202  Tramiprosate (USAN)
            D07869  Donepezil (INN)
            D08174  Memantine (INN)
            D08555  Tacrine (INN)
            D08867  Bapineuzumab (USAN/INN)
            D08869  Begacestat (USAN/INN)
            D09010  Tarenflurbil (USAN/INN)
            D09377  Semagacestat (USAN/INN)
            D09713  Gantenerumab (USAN/INN)
            D09869  Avagacestat (USAN)
            D09917  Latrepirdine (USAN/INN)
            D09918  Latrepirdine dihydrochloride (USAN)
            D10058  Solanezumab (genetical recombination) (JAN)
///
